Larvol Delta - Study-of-Novel-Types-1-and-3-Oral-Poliomyelitis-Vaccines

nOPV3 - PATH, Batavia Pharma

nOPV1 - PATH, Batavia Pharma

http://clinicaltrials.gov/ct2/show/NCT04529538

Mar 9, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next